brilique 90 mg compresse orodispersibili
astrazeneca ag - ticagrelorum - compresse orodispersibili - ticagrelorum 90 mg, mannitolum, cellulosum microcristallinum, crospovidonum, xylitolum, calcii hydrogenophosphas, natrii stearylis fumaras, hydroxypropylcellulosum, silica colloidalis anhydrica, pro compresso corresp. natrium 0.53 mg. - inibizione piastrinica in combinazione con acido acetilsalicilico - synthetika
ferro ati 100
azienda terapeutica italiana a.t.i. s.r.l. - ferro destrano - ferro destrano - 100 milligrammo (i), ferro destrano - 100 mg - iron dextran
fasenra pen 30 mg /1 ml lnjektionslösung
astrazeneca ag - benralizumabum - lnjektionslösung - benralizumabum 30 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - schweres eosinophiles asma - biotechnologika
bydureon bcise 2 mg depot-lnjektionssuspension in einem autoinjektor
astrazeneca ag - exenatidum - depot-lnjektionssuspension in einem autoinjektor - exenatidum 2 mg, saccharum, poly(lactidum-co-glycolidum) 50/50 (0.40 - 0.49 dl/g), triglycerida media, ad suspensionem pro dosi. - antidiabetico - synthetika
calquence 100 mg capsule rigide
astrazeneca ag - acalabrutinibum - capsule rigide - acalabrutinibum 100 mg, cellulosum microcristallinum silicificatum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium max. 0.25 mg, magnesii stearas, kapselhülle: gelatina, e 172 (flavum), e 132, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. - chronisch lymphatische leukämie (cll) - synthetika
trixeo aerosphere 5/7.2/160 μg druckgasinhalation, suspension
astrazeneca ag - budesonidum, glycopyrronium, formoteroli fumaras dihydricus - druckgasinhalation, suspension - budesonidum 160 µg, glycopyrronii bromidum 9 µg corresp. glycopyrronium 7.2 µg, formoteroli fumaras dihydricus 5 µg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, calcii chloridum dihydricum, norfluranum, ad suspensionem pro dosi. - bpco - synthetika
truqap 160 mg compresse rivestite con film
astrazeneca ag - capivasertibum - compresse rivestite con film - capivasertibum 160 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 1.82 mg, magnesii stearas, Überzug: hypromellosum, copovidonum k 28, macrogolum 3350, polydextrosum, triglycerida media, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - carcinoma della mammella - synthetika
truqap 200 mg compresse rivestite con film
astrazeneca ag - capivasertibum - compresse rivestite con film - capivasertibum 200 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 2.28 mg, magnesii stearas, Überzug: hypromellosum, copovidonum k 28, macrogolum 3350, polydextrosum, triglycerida media, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - carcinoma della mammella - synthetika
symbicort 100/6 turbuhaler polvere per inalazione
astrazeneca ag - budesonidum, formoteroli fumaras dihydricus - polvere per inalazione - budesonidum 100 µg, formoteroli fumaras dihydricus 6 µg, lactosum monohydricum, ad pulverem pro dosi. - antiasthmatikum, la bpco - synthetika
symbicort 200/6 turbuhaler polvere per inalazione
astrazeneca ag - budesonidum, formoteroli fumaras dihydricus - polvere per inalazione - budesonidum 200 µg, formoteroli fumaras dihydricus 6 µg, lactosum monohydricum, ad pulverem pro dosi. - antiasthmatikum, la bpco - synthetika